Soumyadip Sahu

5PUBLICATIONS
104CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 29, 2025
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

Leanne G Ahronian, Soumyadip Sahu, Minjie Zhang

|Sep 20, 2023
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.

Suman Mukhopadhyay, Hsin-Yi Huang, Ziyan Lin

|May 03, 2023
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer.

Jiehui Deng, David H Peng, David Fenyo

|Jul 08, 2022
DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome.

Kayla Guidry, Varshini Vasudevaraja, Kristen Labbe

|Jul 31, 2020
InsP7 is a small-molecule regulator of NUDT3-mediated mRNA decapping and processing-body dynamics.

Soumyadip Sahu, Zhenzhen Wang, Xinfu Jiao

Pageof 1

Frequent Collaborators

4 joint publications

Kwok-Kin Wong

3 joint publications

Michela Ranieri

3 joint publications

Jiehui Deng

2 joint publications

Alfonso Lopez